Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 05 Apr 2023
According to a new study led by UCL researchers, wearable technology like smart watches could be used to identify people who are more likely to experience heart failure and irregular heartbeats later in life.
Read Full NewsIn this Neuropathways piece, Kevin Chang, PharmD, explores the complexities of remyelination in multiple sclerosis and the potential of Wnt/β-catenin signaling as a therapeutic target.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on RBD as a prodromal marker for synucleinopathies!
Psoriatic Arthritis in 2025: Year in Review
Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval
1.
Mapping lifelong chronic health risks for childhood cancer survivors
2.
Coffee, Tea Tied to Lower Risk of Head and Neck Cancer
3.
Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.
4.
In schizophrenia, sexual dysfunction is frequent.
5.
Gene therapies for BCG-unresponsive bladder cancer have high response rates.
1.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
2.
A Comprehensive Guide to Carcinoma in Situ: Types, Risks, and Preventive Measures
3.
Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization
4.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
5.
How to Manage Dic with the Right Treatment Approach
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge